Abstract
A female patient with eosinophilia and cardiac symptoms was found to have a unique chromosomal aberration [t(4;7)(q11;p13)] of bone-marrow precursors. The disorder was classified as a chronic myeloproliferative syndrome with eosinophilia. Due to a significant increase in the white blood cell and eosinophil count during initial treatment with prednisone and hydroxyurea, Interferon alpha-2a was administered at a dose of 3–5×106 I.U. s.c., five times per week, and induced a long-term complete haematological and cytogenetic response. The clinical features of this case are presented and discussed in the context of the current literature.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 26 June 1999 / Accepted: 3 September 1999
Rights and permissions
About this article
Cite this article
Schöffski, P., Ganser, A., Pascheberg, U. et al. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration. Ann Hematol 79, 95–98 (2000). https://doi.org/10.1007/s002770050018
Issue Date:
DOI: https://doi.org/10.1007/s002770050018